Malaria Diagnostics Market 2025 Size, Share, Trends & Forecast to 2030

The malaria diagnostics market size is projected to grow from US$ 782.57 million in 2022 to US$ 1,200.24 million by 2030; the market is estimated to record a CAGR of 5.5% during 2022–2030.

The malaria diagnostics market size is projected to grow from US$ 782.57 million in 2022 to US$ 1,200.24 million by 2030, at a CAGR of 5.5% during 2022–2030 .

Market overview

The malaria diagnostics market is expanding steadily owing to the persistent burden of malaria in endemic regions, increased screening initiatives, and growing availability of rapid and accurate testing solutions . Investments from governments and global health organizations to improve early detection and disease management continue to support market growth, particularly in low- and middle-income countries .

Malaria Diagnostics Market Segmentation

By Technology

  • Microscopy

  • Rapid Diagnostic Tests

  • Molecular Diagnostic Tests

Microscopy remains an important standard in many public health settings, while rapid diagnostic tests are widely used for point-of-care screening in remote areas . Molecular diagnostic tests are gaining traction for their high sensitivity and specificity, especially in reference and research laboratories .

By End User

  • Hospitals and Clinics

  • Diagnostic Centers

Hospitals and clinics account for a significant share due to high patient footfall and integrated treatment pathways, whereas diagnostic centers are key hubs for large-scale testing and surveillance programs .

Key growth drivers include ongoing malaria elimination programs, increasing adoption of rapid diagnostic tests, and technological advancements improving test accuracy and turnaround time . Trends such as multiplex testing panels, portable point-of-care platforms, and digital reporting tools are further enhancing the efficiency of malaria diagnosis and surveillance .

Market leaders and key company profiles

Prominent players operating in the malaria diagnostics market include:

  • Access Bio., Inc.

  • Abbott Laboratories

  • Premier Medical Corporation Pvt. Ltd.

  • Sysmex Partec GmbH

  • bioMérieux

  • Beckman Coulter, Inc.

  • Siemens Healthineers

  • Leica Microsystems GmbH

  • Nikon Corporation

These companies focus on expanding rapid test portfolios, improving molecular assay performance, and strengthening distribution networks in malaria-endemic regions to support timely and accurate diagnosis .

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients get solutions to their research requirements through our syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.

Contact Us:

If you have any queries about this report or if you would like further information, please get in touch with us:
Contact Person: Ankit Mathur
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876

Also Available in :Korean German Japanese French Chinese Italian Spanish


amy aadsma

1 Blog posting

Komentar